TORRE, ELENA
TORRE, ELENA
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report
2021-01-01 Morsia, E.; Goteri, G.; Torre, E.; Garvey, K. B.; Discepoli, G.; Tassoni, A.; Mancini, S.; Giantomassi, F.; Poloni, A.; Olivieri, A.; Rupoli, S.
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases
2022-01-01 Morsia, E; Torre, E; Marrara, F; Battila, I; Fiorentini, A; Scortechini, Ar; Offidani, M; Svegliati-Baroni, G; Bendia, E; Olivieri, A; Tarantino, G; Rupoli, S
Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region
2023-01-01 Pileri, Alessandro; Morsia, Erika; Zengarini, Corrado; Torre, Elena; Goteri, Gaia; Quaglino, Pietro; Pimpinelli, Nicola; Paulli, Marco; Pileri, Stefano A; Zinzani, Pier Luigi; Rupoli, Serena
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights
2024-01-01 Morsia, Erika; Torre, Elena; Martini, Francesco; More', Sonia; Poloni, Antonella; Olivieri, Attilio; Rupoli, Serena
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis
2022-01-01 Morsia, E; Torre, E; Marrara, F; More', S; Petrini, M; Manieri, Vm; Gurgoglione, L; Gini, G; Offidani, M; Olivieri, A; Rupoli, S
Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma
2021-01-01 Rupoli, S; Goteri, G; Morsia, E; Torre, E; Garvey, Kb; Giantomassi, F; Campanati, A; Offidani, Am; Brandozzi, G; Giorgio, M; Simonacci, M; Olivieri, A
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications
2022-01-01 Morsia, E.; Torre, E.; Poloni, A.; Olivieri, A.; Rupoli, S.
P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS?
2022-01-01 Morsia, E.; Torre, E.; Tarantino, G.; Svegliati Baroni, G.; Goteri, G.; Mancini, S.; Tassoni, A.; Alessandro, F.; Olivieri, A.; Rupoli, S.
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints
2022-01-01 Rupoli, Serena; Goteri, Gaia; Morsia, Erika; Torre, Elena; Giantomassi, Federica; Campanati, Anna; Offidani, Anna Maria; Molinelli, Elisa; Brandozzi, Giuliano; Serresi, Stefano; Giacchetti, Alfredo; Bugatti, Leonardo; Filosa, Giorgio; Mozzicafreddo, Giorgio; Simonacci, Marco; Olivieri, Attilio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report | 1-gen-2021 | Morsia, E.; Goteri, G.; Torre, E.; Garvey, K. B.; Discepoli, G.; Tassoni, A.; Mancini, S.; Giantomassi, F.; Poloni, A.; Olivieri, A.; Rupoli, S. | |
| Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases | 1-gen-2022 | Morsia, E; Torre, E; Marrara, F; Battila, I; Fiorentini, A; Scortechini, Ar; Offidani, M; Svegliati-Baroni, G; Bendia, E; Olivieri, A; Tarantino, G; Rupoli, S | |
| Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region | 1-gen-2023 | Pileri, Alessandro; Morsia, Erika; Zengarini, Corrado; Torre, Elena; Goteri, Gaia; Quaglino, Pietro; Pimpinelli, Nicola; Paulli, Marco; Pileri, Stefano A; Zinzani, Pier Luigi; Rupoli, Serena | |
| Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights | 1-gen-2024 | Morsia, Erika; Torre, Elena; Martini, Francesco; More', Sonia; Poloni, Antonella; Olivieri, Attilio; Rupoli, Serena | |
| Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis | 1-gen-2022 | Morsia, E; Torre, E; Marrara, F; More', S; Petrini, M; Manieri, Vm; Gurgoglione, L; Gini, G; Offidani, M; Olivieri, A; Rupoli, S | |
| Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma | 1-gen-2021 | Rupoli, S; Goteri, G; Morsia, E; Torre, E; Garvey, Kb; Giantomassi, F; Campanati, A; Offidani, Am; Brandozzi, G; Giorgio, M; Simonacci, M; Olivieri, A | |
| Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications | 1-gen-2022 | Morsia, E.; Torre, E.; Poloni, A.; Olivieri, A.; Rupoli, S. | |
| P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS? | 1-gen-2022 | Morsia, E.; Torre, E.; Tarantino, G.; Svegliati Baroni, G.; Goteri, G.; Mancini, S.; Tassoni, A.; Alessandro, F.; Olivieri, A.; Rupoli, S. | |
| Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints | 1-gen-2022 | Rupoli, Serena; Goteri, Gaia; Morsia, Erika; Torre, Elena; Giantomassi, Federica; Campanati, Anna; Offidani, Anna Maria; Molinelli, Elisa; Brandozzi, Giuliano; Serresi, Stefano; Giacchetti, Alfredo; Bugatti, Leonardo; Filosa, Giorgio; Mozzicafreddo, Giorgio; Simonacci, Marco; Olivieri, Attilio |